throbber
The Metabolic &
`
`Molecular Bases of
`Inherited Disease
`
`eighth edition
`
`
`
`\
`
`EDITORS
`“.
`
`
`ASSOCIATE EDiTone
`
`Charles R. Scriver, M.D.C.M.
`
`a
`
`Barton Childs. MD.
`
`Arthur L. Beaudet, MD.
`
`Kenneth W. Kinzler, Ph.D.
`
`William S. Sly, MD.
`David Valle, MD.
`
`Bert Vogelstein, MD.
`
`McGRm-v-Hiu.
`
`Medical Publishing Division
`
`San Francisco Auckland Bogota Caracas Lisbon London Madrid Mexico City
`St. Louis
`New York
`Milan Montreal New Delhi
`San Juan Singapore Sydney Tokyo Toronto
`“
`m
`Page 1 of 26
`
`Horizon Exhibit 2003
`Horizon Exhibit 2003
`Lupin v. Horizon
`Lupin v. Horizon
`IPR2017-01160
`IPR2017—01160
`
`Page 1 of 26
`
`

`

`Mchw-Hi ll
`A Division of’i heMchw‘Hiii Companies
`
`32
`
`The Metabolic and Molecular Bases of Inherited Disease, 8th Edition
`
`Copyright © 2001, 1995, 1989, 1983, 1978, 1972, 1966, 1960 by The McGraw-Hill Companies. Inc. Formerly published as
`The Metabolic Basis of Inherited Disease. All rights reserved. Printed in the United States of America. Except as
`permitted under the United States Copyright Act of 1976. no part of this publication may be reproduced or distributed in
`any form or by any means, or stored in a database or retrieval system, without the prior written permission of the
`'
`publisher.
`'
`
`1234567890 KGPKGP 09876543210
`
`13st
`
`'
`
`i
`'-
`
`"
`
`0—07—913035—6
`(vol. 1)
`0—07—136319—X
`(vol. 2)
`0-07-136320-3
`(vol. 3)
`0-07-136321-1
`(vol. - 4)
`0—07—136322—X
`This book was set in Times Roman by Progressive Information Technologies, Inc.
`The editors were Martin J. Wonsicwiez, Susan R. Neujaiin, and Peter J. Boyle;
`the production supervisor was Richard Ruzycka; the text designer was José R. Fonfriag
`the cover designer was Elizabeth Sehmitz; Barbara Littlewood prepared the index.
`Quobccor Printin'glKingsport was printer and binder.
`This book is printed on acid-free paper.
`
`'
`
`\
`
`Library of Congress Cataloging-in-Publication Data
`
`The metabolic and molecular bases of inherited disease I editors,
`Charles R. Scriver ... [et aI.].—8th ed.
`p.;
`cm.
`
`includes bibliographical references and index.
`ISBN 0—07—913035-6 (set)
`1. Metabolism, Inborn errors of
`Scriver, Charles R.
`
`2. Medical genetics.
`
`\
`
`i
`'
`
`I
`
`3. Pathology, Molecular, I.
`
`[DNLM: 1. Hereditary Diseases. 2. Metabolic Diseases. 3. Metabolism, Inborn Errors.
`WD 200 M5865 2001]
`RC627.8 . M47 2001
`
`616’.()42—d(:21
`
`INTERNATIONAL EDITION
`ISBNs 0—07—1 16336-0
`
`007060957
`
`(Vol. I)
`0—07-118833-9
`(vol. 2)
`0-07—118834—7
`(v01. 3)
`0—074 18835—5
`(vol. 4)
`007-118836—3
`Copyright © 2001. Exclusive rights by The McGraw—Hill Companies, Inc. for manufacture and export.
`This book cannot be exported from the country to which it is consigned by McGraw-Hill. The International
`Edition is not available in North America.
`
`Page 2 of 26
`
`Page 2 of 26
`
`

`

`This material may be protected by Copyright law (Title 17 U.S. Code)
`
`Page 3 of 26
`
`

`

`
`4934 PART 21 / MEMBRANE TRANSPORT DISORDERS
`
`lysine in intestinal biopsy specimens have
`fluxes of
`confirmed that the defect indeed localizes to the hasolateral
`cell surface. Similar cellular localization of the defect in the
`kidney tubules is suggested by infusions of citrulline, which
`cause not only citrullinuria but also significant argininuria
`and ornithinuria. Because citrullinc and the cationic amino
`acids do not share transport mechanisms in the tubules,
`part of the citrnllinc is converted to arginine and then to
`ornithine in the tubule cells during reabsorption. A
`hanilateral transport detect prohibits antiluminal either of
`arginine and ornithine, which accumulate and escape
`through the luminal membrane into the urine. The genetic
`mutations in LPI and possibly in all cationic aminoacid-
`urias apparently lead to kinetic abnormalities in the
`transport protein[s} of the cationic amino acids. This is
`suggested by the fact that increasing the tubular load of a
`single cationic amino acid by intravenous infusion increases
`its tubular reabsorption, but reabsorption remains sub-
`normal even at high loads. he other cationic amino acids are
`able to compete for the same transport site{s] also in LPI.
`but an increase in the load of one cationic amino acid
`frequently leads to net secretion of the others.
`The plasma membrane of cultured fibroblasts shows a
`defect in the trans-stimulated efflux of the cationic amino
`acids; i.e., their flux out of the cell is not stimulated by
`cationic amino acids present on the outside of the cell as
`efficiently as it is in the control fibroblasts. The percent of
`trans-stimulation of homoarginine efflux in the fibroblasts
`of the heterozygotes is midway between that of the patients
`and the control subjects.
`rl‘he exact cause of hyperamnlonemia in LPI remains
`unknown. The enzymes of the urea cycle have normal
`activities in the liver, and the brisk excretion of orotic acid
`during hypel'alnmonemia supports the view that N-acet-
`ylglutamate and carbamyl phosphate are formed in
`sufficient iluantities. Low plasma concentrations of al'ginine
`and ornithine suggest that the malfunctioning ol’ the cycle is
`caused by a deficiency of intramitochondrial ornithine. This
`hypothesis is supported by experiments in which hyper-
`ammonemia after protein or amino nitrogen loading is
`prevented by intravenous infusion of arginine or ornithine.
`Citrulline, a third urea cycle intermediate, also abolishes
`hyperammonemia if given orally, because, as a neutral _
`amino acid, it is welt-absorbed from the intestine. Ornithine
`deficiency in LPI has recently been questioned because
`cationic amino acids and their nonmetabolized analogues
`accumulate in higher-than-normal amounts in intestinal
`biopsy specimens and cultured fibroblasts
`from LPI
`patients in vitro and the concentrations of the cationic
`amino acids in liver biopsy samples are similar or higher in
`the patients when compared to these concentrations in the
`control subjects. If hyperammonelnia is not due to simple
`deficiency of ornithine, it could be caused by inhibition of
`the urea cycle enzymes by the intracellularly accumulated
`lysine; by a coexisting defect in the mitochondrial ornithine
`transport necessary for the function of the urea cycle; or by
`actual deficiency of ornithine in the cytoplasm caused by
`abnormal pooling of the cationic amino acids into some cell
`organelle(s), most likely lysosomes. The latter two exploita-
`tions imply that the tramport defect is expressed also in the
`organellc(s).
`including
`in practically all proteins,
`. Lysine is present
`collagen. Lysine deficiency may cause many of the features
`of the disease that are not corrected by prevention of
`hyperanlmonemiu, including enlargement of the liver and
`spleen, poor growth and delayed bone age, and osteoporosis.
`Oral lysine supplements are poorly tolerated by the patients
`
`s—N—aeetyl-L—
`because of their poor intestinal absorption.
`lysine, but not homoeitrullinc, efficiently increases plasma
`concentration of lysine in the patients, but acctyllysinc or
`other neutral
`lysine analogues have not been used for
`supplementation.
`7. Recently, a fiZZ-amino-acid retroviral receptor (murinc
`leukemia viral receptor RECI) with 12 to 14 potential
`membrane-spanning domains has been cloned. The physio-
`logical role of the receptor was soon found to be that of a
`cationic amino acid transporter at the cell membrane; the
`protein was hence renamed MCAT—l. mouse cationic amino
`acid transporter-'1. The functional characteristics of the
`transporter are similar to those of system y”, a widely
`expressed Nat-independent transport system for cationic
`amino acids. The human counterpart of the mouse RECl
`gene, encoding the retroviral receptor-transport protein,
`has been assigned to chromosome 13q12—q14 and named
`ATRCI. MCAT-l (and 3"”) activity is not expressed in
`rodent liver, but two other related cationic amino acid
`transport proteins, formed presumably as a result of
`alternative splicing—Tea (T cell early activation; expres-
`sed also lll activated Tand B lymphocytes) and MCAT—Z—
`are probably responsible for the low-affinity transport of
`cationic amino acids that is characteristic of (mouse) liver.
`Studies addressing the A'l‘RCl gene as well as the Tea and
`MCA'BZ genes as candidate genes for LPI are under way.
`8. Treatment
`in lyfiiinuric protein intolerance consists of
`protein restrictio and supplementation with oral citrulline,
`3 to 8 g daily during meals. Patients are encouraged to
`increase their protein intake modestly during citrulline
`supplementation, but aversion to protein in most patients
`effectively inhibits them from accepting more than the
`minimal
`requirement. The treatment clearly improves
`the growth and well-being of the patients. Pulmonary
`complications (interstitial pneumonia, pulmonary alveolar
`proteinosis, cholesterol granulomas, and respiratory insuf-
`ficiency} have occasionally responded to early treatment
`‘ with high-dose prednisolone, or to bronchoalveolar lavages.
`No therapy is known for the associated renal disease and
`renal failure.
`9. The clinical and biochemical findings in other cationic
`alninoacitlurias differ slightly from those in lysinuric
`protein intolerance. The symptoms of the index case with
`hyperdibasic aminoaciduria type 1 resemble those of LPI,
`but
`the other affected members of
`the pedigree are
`clinically healthy. The Japanese patient with isolated
`lysinurla has severe growth failure. seizures, and mental
`retardation. Her transport defect is apparently limited to
`lysine, and hyperammonemia is not a feature of the disease.
`
`Perhccntupa and Visakorpi described the first three patients with
`“familial protein intolerance with deficient
`transport of basic
`amino acids" in 1965.1 The disease is now called lysinuric protein
`intolerance (LPI) (MJM 222700} or “hyperclibasic aminoaciduria
`type 23‘2—5 Over 100 patients with this autosomal recessive
`disease have been described or are known to me; 4] of them are
`Finns or Finnish Lappsfi‘52 The incidence in Finland is
`1
`in
`60,000 births but varies considerably within the couiitry.2-5-°’
`Patients of black and while American,
`Japanese, Turkish,
`Moroccan, Arab, Jewish. Italian, French. Dutch. Irish, Norwegian,
`Swedish, and Russian origin have also been described. The
`fascinating combination in the disease of urea cycle failure,
`expressed as postprandial hyperammonemia, and a defect in the
`transport of the cationic amino acids lysine, argininc, and ornithine
`in the intestine and kidney tubules has led to extensive studies of
`the mechanisms that link these two phenomena. The mechanisms
`are still partly unresolved, and the sequence of events leading to
`hyperammonemia is unclear. We can simplify our knowledge by
`
`Page 4 of 26
`
`Page 4 of 26
`
`

`

` CHAPTER T92 f LYSINURIC PROTEIN INTOLERANCE AND OTHER CATIONIC AMINOACIDURIAS ' I
`
`GENETIC DEFECT 0F
`
`EPITHELIAL LYS. ARG Br ORN TRANSPORT
`/ I
`\
`I INTESTINAL
`I TUBULAR FIE—
`TRANSPORT INTO
`ABSORPTION
`ABSORPTION
`LIVER CELLS
`
`DEFICIENCY OF
`
`BEEN. ARE. 3.
`PROTEIN MAL-
`NUTRITION
`
`—“‘-—‘—"'
`
`7.- ’77
`[MPAIRED UREA CYCLE I
`POST PRANDIAL HYPER-
`AI'II'I MONEMIA
`I
`
`NAUSEA, PROTEIN
`AVERSION
`
`SEIZURES, STUPOR
`COMA
`
`
`
`GROWTH FAILURE I LOSTEOPDROSISI
`I HEPATOMEGALY I
`Fig. 192-1 The suggested pathogenesis of Iyslne, arginine, [and
`ornlthlne deflelency, hyperammonemia, and aversion to protein in
`LPI.
`
`saying that. hyperammonemia is caused by “functional defi—
`ciency” of the urea cycle intermediates arginine and ornithlne in
`the urea cyclc“'”"‘1*Sal (Fig. 192-1). LPl has also been a productive
`model for studies of cellular transport: It is the first human disease
`where the transport defect has been localized to the basolatcral‘t
`(antiluminal) membrane of the epithelial cells.55—57 Further, in LPI
`the parcnchymal cells show a defect in the trans-stimulated efliux
`of the cationic amino acids, suggesting that
`the hasolateral
`membrane of the epithelial cells and the plasma membrane of the
`parenchynral cells have analogous functionssstas‘
`Recently, the first candidate gene for LP], ATRCI, encoding a
`human cationic amino acid transporter, has been mapped to the
`long arm of chromosome 13 (l’.iqu—ql4).“’O Without further proof,
`it is intriguing to hypothesize how a mutation in this or in a
`functionally similar gene or in genes encodi g regulatory proteins
`of these transporters might lead to the membr nc—selcctive cationic
`amino acid transport defect of IPI and to the complicated clinical
`features of the disease.
`.
`Several patients with variant forms of cationic aminpaeiduria
`have been described in which the protein tolerance often is better
`than in LPI and the selectivity and severity of cationic amino—
`aciduria differs.23‘25-33mm In the report by Whelan and Scriver‘51
`only the history of the index case suggested hyperammoncmia, but
`other members of the pedigree have been symptom—free. The
`inheritance of this hyperdibasic aminoaeidurla type 1 is autosomal
`dominant, implying that the patients are heterozygous for LP] or
`another type of hypcrdihasic aminoaciduria.
`
`CLINICAL ASPECTS
`
`Lysinuric Protein Intolerance
`Natural Course of the Disease. The gestation and delivery of
`infants with LPI has been i.ineventful."'—“’-9—''v35 Breast—fed infants
`usually thrive because of the low protein concentration in human
`milk, but symptoms of hyperammonemia may appear during the
`neonatal period and reflect exceptionally low protein tolerance or a
`high protein content in the breast milk, Nausea, vomiting, and. mild
`diarrhea appear usually within 1 week of Weaning or another
`increase in the protein content of the meals. Soy-based formulas
`are perhaps slightly better tolerated than cow’s milk. The infants
`are poor feeders, cease to thrive, and have marked muscular
`' hypotonia. The patient's liver and spleen are enlarged from the
`neonatal period-onward. The association of episodes of vomiting
`with high protein feeds is not always apparent to the parents and
`may remain unnoticed even by trained physicians for years. Thus,
`n
`
`Page 5 of 26
`
`the diagnosis frequently has been delayed until the school age or
`even adultlrood.35'47'63
`Around the age of 1 year, most patients begin to reject cow’s
`milk, meat, fish, and eggs. The diet then mainly contains cereals
`cooked in water, potatoes, rice and vegetables, fruits and juices,
`bread, butter, and candies. The frequency of vomiting decreases on
`this diet, but accidental
`increases in protein intake lead to
`dizziness, nausea, and vomiting. A few patients have lapsed into
`coma, to the point where the EEG became isoelectr'rc when the
`children were tube—fed with high—protein foodsFT‘E-‘m-“A? Enteral
`alimentation and total parenteral nutrition may cause symptoms in
`patients who have remained undiagnosed, because the protein or
`amino acid loads often exceed patient‘s tolerance. Prolonged,
`moderately increased protein intake may lead to dizziness,
`psychotic periods. chronic abdominal pains, or suspicion of
`abdominal emergencies.
`trau—
`frequently, often after minor
`Bone fractures occur
`1113.4‘14'30'35'63 ‘65 In a Finnish series, 20 of 29 patients (69 percent)
`had suffered from fractures of the long bones or of compression
`fractures of the lumbar spine; 10 (34 percent) had had more than 2
`fractures during the
`18—year
`follow—up.“*55 Most
`fractures
`occurred before the age of 5 years. Symptoms of osteoarthrosis
`soften begin at the age of 30 to 40 years. The radiologic signs of
`osteoporosis are usually severe before puberty but decrease with
`advancing age. The effect. of citrullinc therapy on osteoporosis is
`minimal.
`Our accumulating experience with the late complications
`associated with the disease,
`together with recent
`reports of
`patients from outside Finland, suggest that in a sizable. proportion
`of the patients the classic symptoms of protein intolerance may
`remain unnoticed.
`Instead,
`the patients may present with
`interstitial lung disease or respiratory insufficiency! or have renal
`glomerular' or glometulotubular disease with or without renal
`insufficiency as the first clinical finding (see “Complications and
`Autopsy Findings" below).
`
`Physical Findings. Muscular hypotonia and hypotrophy are
`usually noticeable from early infancy but improve with advancing
`age.35 Most patients are unable to perform prolonged physical
`exercises, but acute performance is relatively good. The body
`proportions of patients after the first couple of years of life are
`characteristic: the extremities are thin, but the front view of the
`body is squarelikc with abundant centripetal subcutaneous fat. The
`hair is thin and sparse, the skin may be slightly hyperelastic, and
`the nails are normal. The liver is variably enlarged, and the spleen
`is often palpable and is large by ultrasound.
`the age of
`Patients who have remained undiagnosed until
`several years have had characteristics typical of protein-calorie
`malnutrition and frequently resemble patients with advanced
`celiac disease. The subcutaneous fat may be reduced and the skin
`“loose” and “too large for the body" (Fig. 192-2}.
`The ocular fundi have been normal by ophthalmoscopy.35 0f
`20 patients studied, l4 had minute opacities in the anterior fetal Y
`suture of both lenses. In 10 patients, the opacities were surrounded
`by minute satellites. The opacities were never large enough to
`cause visual
`impairment and have remained stable,
`in some
`patients now for over 25 years. The mechanism underlying the lens
`abnormalities is unknown.“
`The dentition of the patients has been normal, and the patients
`do not appear to be especially prone to caries, despite the high
`carbohydrate content of the diet._
`
`for
`and lengths have been normal
`Growth. Birth weights
`gestational age, and postnatal growth is normal before weaning.
`The growth curves then begin to deviate progressively from the
`normal mean, and, at the time of diagnosis, 16 of 20 Finnish
`patients were more than 2 SD below the mean height, 12 patients
`were more than 3 SD. 6 patients more than 4 SD, 2 patients more
`than 5 SD, and 1 patient 6 SD below the mean.” Skeletal
`maturation is considerably delayed?!“ The bones usually mature
`
`Page 5 of 26
`
`

`

`
`4936 PART 21 I MEMBRANE TRANSPORT DISORDERS
`
`
`
`Fig. 192~2 Two children with LPI. The pictures were taken at the time
`of diagnosis. A, Child 12 years old. 8, Child 6 years old. Note the
`prominent abdomen, hypotrophlc muscles, and “loose” skin. The
`
`slowly and linearly without a pubertal catch-up spurt, and most
`patients have not reached skeletal maturity by the agc of 20 years.
`The final height of the patients has almost invariably been closer to
`the normal
`than the height measured at the time of diagnosis,
`because of therapy and the late cessation of growth. The head
`circumferences have been normal for age.
`The body ifiroportions are normal, but with advancing age the
`moderate centripetal obesity, which is present from early child
`hood, becomes more obvious.
`
`Skeletal Manifestations and Bone Metabolism. Osteoporosis is
`often recognizable in skeletal radiographs and has occasionally
`been the leading Sign of 1.1590553"65 Two—diirds of the patients
`have had fractures, half of which have occurred after insignificant
`trauma. All fractures have healed properly within a normal time. _
`The skull and sella lurcica have been normal in roentgenograms.
`Over 70 percent of the patients have some skeletal abnor—
`malities. either osteoporosis, deformations, or early osteoartin'o—
`snob-3’55 In radiographs of 29 Finnish patients. osteoporosis was
`present in l3; the cortices of the long bones were abnormally thin
`in 5; the vertebrae had endplate impressions in 8; metaphyses were
`rickets—like in 2'. and cartilage showed early destruction in 3. The
`cortex of the metacarpal bones was characteristically thickened in
`7.6"“ Morphometric analyses of bone biopsy samples showed
`moderate to severe osteoporosis in eight of nine patients studied;
`trabecular bone and osteoid volume were markedly l'ozlut‘,ed_E'5
`After (ioublcalabcling of bones with tetracycline in viva, barely
`identifiable single lines were detected, suggesting poor bone
`deposition;
`the findings resembled those in severe malnutri-
`tion.68 ’74 The number of osteoblasts and osteoclasts was low, and
`the extent of ostcoid along the bone surfaces was low or normal in
`all specimens studied.
`Laboratory tests for evaluation of calcium and phosphate
`metabolism have given unremarkable ICSUltS.35‘63"65 Serum
`calcium and phosphate concentration, urinary excretion ol’calcitlln
`and phosphate, serum magnesium, estradiol, testosterone, thyroid-
`slimuiating hormone, cortisol, vitamin D metabolites [25~(OI—l)2-
`D,
`l,25-(Ol[)2—D and 24.25—(011h-D'], parathyroid hormone,
`calcitonin, and ostcocalein concentrations have all been within
`the reference range.
`
`‘l:
`thorax of the child In A Is deformed and her trunk shortened because
`of osteopoiosla and pathologic fractures of the vertebrae.
`\
`
`The daily urinary excretion of hydroxyproline is significantly
`increased during pubertal growth, but half of the adult patients also
`have
`supranormal
`excretion
`rates
`(mean
`of
`all
`adults
`212 :L- [03 ttmoilmg; adult reference range, 60 to 180 pmol!
`1112).“ The seruni hytlroxyproline concentration is increased in
`almost all patients irrespective of age. Scrum concentrations of the
`C~terminal propeptide of type [ precoilagen and of the Niterminal
`propcptide of type III procollagen have been normal
`in all
`pediatric patients, but the concentration of the latter increases
`1‘during puberty and remains elevated in adult patients.
`The incorporation of labeled hydl‘oxyprolinc into collagen was
`significantly decreased in cultured LP] fibroblasts as compared
`with age-matched controls at the ages of 5, 14, and 30 years, but
`ther was no difference at the age of 44 years.‘55 Morphometry of
`the collagen fibrils in electron microscopy showed no differences
`between patients and controls.
`
`Liver Pathology. In the youngest patients. the histologic findings
`in liver biopsy specimens have been normal, with only occasional
`fat droplets in the hepatocytesfismlfi In older patients, delimited
`areas in periportal or central parts of the liver lobules contained
`liepatocytes with ample pale cytoplasm and small pyknotic nuclei
`In these cells, the glycogen content is dcc1cascd, and glycogen
`appears in coarse particles. At the borders of the abnormal areas.
`many nuclei are ghostlike and have central
`inclusion bodies
`staining positively with periodic acidischiff. Cytoplasmic fat
`droplets occur especially in the periportal areas. Children who died
`of alveolar proteinosis with multiple organ dysfunction syndrome
`have mostly shown extensive fatty degeneration of the liver but
`minimal or moderate cirrhosis. Inflammatory cells have always
`been absent in the liver biopsy samples.
`Liver changes
`in LPI may reflect generalized protein
`malnutrition, because in kwashiorkor
`liver
`fat
`synthesis
`is
`increased, apolipoprotcin synthesis is decreased. and lipoprotcin
`lipascs are inhibited.76 Similar liver changes have also been
`induced in rats by lysine and arginine deprivation.W
`
`in
`Performance in Adult Life. Mental development is normal
`most subjects. Performance is decreased, particularly in patients
`with known histories of prolonged hyperammonemia. Altogether,
`
`Page 6 of 26
`
`Page 6 of 26
`
`

`

`
`CHAPTER 192 / LYSINURIC PROTEIN iNTOLERANCE AND OTHER CATIONIC AMINOACIDURIAS 4937
`
`about 20 percent of the patients with LPI reported in the literature
`or otherwise known to me are mentally retarded. Convulsions are
`uncommon, but periods of
`stupor have occasionally been
`misinterpreted as psychomotor seizures.15 Four patients have had
`psychotic periods, which have clearly been precipitated by
`prolonged moderate 11ypcrarnrnonemia.35
`Neuropsychologic evaluation of the patients suggests that
`mathematical and other abstract skills are particularly vulnerable
`to hyperammonernia. Treatment with a low—protein diet and
`citrullinc supplementation' “453 (see “Treatment” below) has
`significantly improved the life quality of the patients. Episodes of
`vomiting and other signs of hyperammonemia have become a rare
`exception. The patients who underwent prolonged periods of
`hyperammonemia in early infancy and childhood and who
`appeared severely retarded at the first presentation have consider-
`ably and continuously improved their performance during therapy.
`All Finnish patients are now able to take care of the activities of
`daily life, and none of them is institutionalized The most severely
`retarded patient, who had an IQ of 40 at the age of 12 years, lives
`now at the age of 40 in the custody of another fatnin apt] is
`capable of taking care of her daily activities; she also works in a
`protected environment outside the home for a few hours a day and
`helps routinely in the household. She is talkative, happy, and
`socially active. At the other end of the spectrum, one patient has
`graduated from a medical School, works successfully air an
`internist, is married, and is a mother of one. Several other patients
`have also graduated from high school or other secondary schools
`and are permanently employed. The physical fiurcss of the patients
`is fair, but their capacity for prolonged heavy work and physicali
`endurance is clearly limited. One patient worked as a construction
`Worker in a building company for a few years, but found the job
`too heavy; another has been an active jogger for years and is
`capable of running 15 km without problems. The oldest patient in
`Finland is now 49 years of age and retired '7 ydhrs ago because of
`back problems. He is mentally and physically active and takes care
`of the household duties of a small farmhouse. A Finnish—born
`patient in Sweden is now 58 years old.'6'2"29 One male and seven
`female patients are married.
`
`Pregnancies of the Patients. The seven mahied women have had
`fifteen pregnancies. One of the mothers was treated 'during the
`pregnancy only with protein restriction;
`the other t’received
`citmllinc supplementation (8 to 14 pills containing lit-414 g I.-
`citi‘ulline daily during meals). Anemia (hemoglobin < 8.5 g/dl)
`occurred in all, and the platelet count decreased to less than
`50 x 1031mm3. A severe hemorrhage complicated two deliveries
`in one patient. Another patient had severe toxemia in her second
`pregnancy. The blood pressure increased to crisis values and she
`had prolonged convulsions and unconsciousness, but she recov-
`ered totally. In a third patient, an ultrasound-guided amniotic fluid
`puncture led to a bleed and loss of the fetus at 35 gestational
`weeks. Despite the mothers’ anemia and severely decreased
`platelet count, other pregnancies and deliveries have been”
`uneventful.
`Of the 14 living children born to the patients, l3 are well at the
`age of 0.5 to 14 years. One child, whose delivery was complicated
`by a severe maternal hemorrhage, has hemiplegia and slightly
`delayed mental development, and another one was late in learning
`to speak but has later developed well.
`One male patient has a healthy son.
`
`Complications and Autopsy Findings. Since the first description
`of LPI in 1965,1 4 children and 1 adult of the 39 known Finnish
`patients have died. and a few pediatric LP] patients have died in
`other countries. A Moroccan patient died with pulmonary
`symptoms and autopsy findings similar to those of the four
`Finnish children (see below),37 and a Japanese patient has had
`long~lasting, slowly progressive interstitial changes in the lungs.36
`An American child with I P}! presented with interstitial pneumonia
`at the age of 27 months and later died of pulmonary alveolar
`»;
`
`three Italian patients with severe
`proteinosis.38 More recently,
`interstitial lung disease have been described.5i One of them died at
`the age of 18 months;
`two others had an accompanying renal
`glomcrular or glomerulotubluar disease. One Arab child had
`Severe respiratory insufficiency as the presenting sign at the age of
`11 years, and had had clubbing of the fingers for 5 years.52 An
`open lung biopsy showed cholesterol casts surrounded by a
`granulomatous process and giant cells; there was a small amount
`of interstitial inflammation and a moderate degree of scarring.
`Electron microscopy demonstrated cholesterol casts around and
`within macrophages and within alveolar cells in the alveolar
`spaces, but no hemorrhage.
`Two of the four Finnish children who died had another
`systemic disease in addition to LP] (SLR; hypothyreosis). In all
`four,
`the fatal courses began as acute or subaeute respiratory
`insufficiency, which progressed to multiorgan failm‘efafls'lm‘” the
`symptoms fulfilled the criteria of the multiple organ dysfunction
`syndromem-i32 Progressive fatigue, cough, and mild to high fever
`were typical. and some children had blood in the splttttlrt.73'80
`Dyspnea with marked air hunger during minimal exercise
`developed. Hemoglobin and platelet values fell, and the values
`of serum ferritin and lactate dehydrogenase, which are high in
`‘ normal circumstances in these patients, increased even further. The
`sedimentation rate was elevated. Arterial oxygen tension was
`decreased, and the children had a severe bleeding tendency. The
`severity of
`liver, kidney,
`and pancreas
`involvement
`in the
`multiorgan failure varied. The pulmonary symptoms lasted from
`2 weeks to 6 months before death.
`The radiologic findings during the acute phase were similar in
`all patients with a fatal course.TH Diffuse, l'cticttlonodular densities
`and, later, signs of rapidly progressing airspace disease appeared
`in the chest radiographs at the mean age of 5 ycafs (range 1.2 to
`10.2 years) (Fig. [92-3]. Two children developed acute respiratory
`insufficiency 2 months after the first radiolog'ic signs of lung
`involvement, bttt one patient had densities for over 2 years and
`another for 12 years before acute exacerbation.
`In one patient, a lung biopsy specimen taken at the time of
`appearance of the reticulonodular densities showed pulmonary
`alveolar proteinosis (Fig. 192—3C). At autopsy, three of the patients
`showed pulmonary alveolar proteinosis, and one had pulmonary
`hemorrhage with cholesterol granulomas. The specimens showed
`accumulations of myelin~like multilamellar structures, simple
`vesicles, granules, amorphous material, and crystals in transmis—
`sion electron microscopy (Fig. l9'2—4t).7'9 Samples from the patient
`with pulmonary cholesterol granulomas contained interstitial and
`intro-alveolar cholesterol crystals and some multilamellar struc-
`tures.
`lt
`is
`interesting that
`similar pulmonary cholesterol
`granul'omas vvene described in the lung biopsy sample of the
`Saudi Arabian child from Israel.52
`
`One adult patient developed acute respiratory insufficiency
`with cough, fever, dyspnea, and hemoptysis at
`the age of 23
`yew-5.7840 Chest radiographs showed interstitial densities and
`airspace disease. Pulmonary function tests
`showed minimal
`obstruction of the distal airways but normal diffusing capacity.
`Extensive microbiologic investigations showed no evidence of
`infection. An open lung biopsy specimen showed bronchiolitis
`obliterans with signs of interstitial pneumonia. Granulation tissue
`polyps obstructed bronchiolar
`lumina,
`alveolar
`septa were
`thickened, and the sample contained a number of infiltrating
`lymphocytes and macrophages as well as signs of alveolar
`hemorrhages; no vaSeulitis nor full—blown alveolar proteinosis
`were found. The cytoccntrifuge preparation made from the lung
`biopsy specimen showed 57 percent macrophages, 15 percent
`neutrophils, and 26 percent lymphocytes of the total cell count.
`The T—helper
`to T—suppressor cell
`ratio was 0.81. Symptoms
`disappeared rapidly and radiologic findings normalized within two
`months during high-dose prcdnisolone treatment. Eight months
`later, the patient relapsed with hemoptysis, but he responded well
`again to an increased corticosteroid dose. New, 5 years later,
`he is symptom—free;
`the results of pulmonary function tests,
`
`Page 7 of 26
`
`Page 7 of 26
`
`

`

`
`4938 PART 21 / MEMBRANE TRANSPORT DISORDERS
`
`Fig. 192-3 A 13-year-old girl with LPI who developed fatal respira-
`tory Insufficiency after a mild respiratory infection. A, Chest
`radiograph at the time 01 the first respiratory symptoms showed
`reticulonodular interstitial densities. 3, Chest radiograph taken two .
`weeks later shows interstitial and alveolar densities. C, Pulmonary
`biopsy specimen shows signs of alveolar proteinosis (hemaioxylin-
`eosin, original magnification x115). (From Farm at 3L7 Used by
`permission.)
`
`high—resolution computed tomography, and radionuclide imaging
`are normal, but the proportion of erythrocytes in the bronchoal—
`veolar lavage fluid is increased.
`Another patient developed chronic, slowly progressive pul-
`monary insufficiency with dyspnea, cough. chest pain. and
`hypoxia at the age of 42 yeal‘s.73’m A bronchoalvcolar lavage
`cuned clinical symptoms in hours. and the response has been as
`good in all of the six relapses that have occurred during the 7 years
`of followup. His chest radiographs show increasing interstitial
`linear and nodular densities. Six years afte

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket